|
- 2018
Emerging role of precision medicine in biliary tract cancersDOI: 10.1038/s41698-018-0064-z Abstract: Emerging role of precision medicine in biliary tract cancers. Yellow boxes highlight US FDA-approved drugs and drugs undergoing clinical investigation as reviewed, with arrows indicating pathway/target activation and blocked lines indicating pathway/target inhibition. BTC targets/pathways discussed are shown in color-coded boxes according to subcellular localization, blue?=?cell surface, orange?=?cytsolic, red?=?mitochondrial, and green?=?nuclear. “↑” denotes over-expression, “Δ” denotes copy number abbreation and/or point mutation, a lighting bolt symbol denotes a synthetic lethal interaction between drug(s) and target(s) liste
|